Key Performance
More- Earnings Score: N/A
- Momentum Score: 1
- True Yield: N/A
- Financial Health Score: N/A
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
PetMed Express, Inc. (Nasdaq: PETS) announced it will report financial results for the fourth quarter and fiscal year ended March 31, 2026, on June 2, 2026 after market close, with a conference call and webcast at 4:30pm Eastern Time. The company also announced a strategic partnership with Rural King to launch pet pharmacy offerings across retail and digital channels.
05/29/2026, 8:00 AM • GlobeNewswire
Cardone Ventures Offers Full Buyout Of PetMed Express, Stock Soars
Cardone Ventures submitted an unsolicited all-cash proposal of $4.25 per share to acquire PetMed Express, valuing the company at approximately $89 million. The offer targets all outstanding shares and aims to improve the pet pharmacy's performance under private ownership.
12/17/2025, 9:12 AM • Benzinga
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
PetMeds launches a holiday product collection emphasizing pet health, wellness, and practical gifts, including grooming products, first aid kits, DNA tests, and supplements for dogs, cats, and horses.
12/10/2025, 8:00 AM • GlobeNewswire
Law firm investigating potential securities law violations by PetMed Express after delayed earnings release caused stock price to drop 11.22%.
11/01/2025, 10:44 AM • GlobeNewswire
PetMed Express is under investigation for potential financial misconduct, including delayed financial reporting, revenue recognition issues, and executive resignations after a whistleblower complaint.
10/13/2025, 2:50 PM • GlobeNewswire
PetMed Express is under investigation for potential financial reporting misconduct, including delayed financial statements, revenue recognition issues, and executive resignations.
10/09/2025, 6:58 PM • GlobeNewswire
PetMed Express, Inc. Investors: Company Investigated by the Portnoy Law Firm
PetMed Express is under investigation for potential securities fraud after delaying its earnings release and annual report filing, which caused stock price declines in June and July 2025.
08/19/2025, 4:35 PM • GlobeNewswire
Law firm Bragar Eagel & Squire is investigating potential securities law violations for four companies, focusing on financial performance issues and alleged fraudulent practices that negatively impacted investor value.
07/23/2025, 7:30 PM • GlobeNewswire
Pomerantz Law Firm is investigating potential securities fraud at PetMed Express, following delayed earnings reports and an internal revenue recognition investigation that caused stock price declines.
07/23/2025, 10:00 AM • GlobeNewswire
Law firm investigating potential securities law violations by PetMed Express after company delayed earnings release and annual report filing due to internal audit and whistleblower complaints about revenue recognition and promotional practices.
07/07/2025, 10:59 PM • GlobeNewswire
PetMed Express delayed its Q4 and fiscal year 2025 earnings release, causing its stock price to drop 11.22% to $3.72 per share on June 11, 2025.
06/28/2025, 10:00 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/03/2026
Company Profile
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.